Femasys Inc. (NASDAQ:FEMY) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Keith J Kendall Other companies: Aquestive Therapeutics, Inc. (CEO and President, Director · Jul 24, 2018 – Mar 10, 2022 · Past) | Director · Jun 14, 2023 – Jun 14, 2023 · Past |
| Kenneth D. Eichenbaum Other companies: InfuSystems Holdings, Inc. (Director · Since at least May 16, 2024) | Director · Since at least Mar 18, 2026 |
| Wendy Perrow Other companies: Bioanalytical Systems Inc (Director · Dec 10, 2015 – Sep 10, 2019 · Past) | Director · Jan 19, 2022 – Jun 21, 2023 · Past |
| Charles Larsen | Director · Since at least Jun 17, 2021 |
| Christine E Thomas | Chief Reg & Clinical Officer · Oct 10, 2023 – Jan 28, 2025 · Past |
| Daniel Scott Currie | Chief Operating Officer · Since at least Jul 3, 2023 |
| Dov Elefant | Chief Financial Officer · Since at least Jul 3, 2023 |
| Edward R Uzialko | Director · Since at least Jun 17, 2021 |
| Gary Thompson | Director · Jun 17, 2021 – Jun 17, 2021 · Past |
| Hoskin Violet Alexandria Kelley | VP, Clinical & Medical Affairs · Jun 17, 2021 – Jun 17, 2021 · Past |
| James H. Liu | Chief Medical Officer · Since at least Aug 21, 2025 |
| Jeffrey Mifek | Chief Clinical and Regulatory Affairs Officer · Since at least Jul 6, 2026 |
| Jeremy Sipos | Chief Technology Officer · Since at least Dec 16, 2025 |
| John Canning | Chief Operating Officer · Since at least Mar 30, 2026 |
| John Moorhead | Director · Since at least Oct 30, 2026 |
| Kathy Lee-Sepsick | Chief Executive Officer, Director · Since at least Aug 7, 2026 |
| Kathy Lee-Sepsick | President and Chief Executive Officer · Since at least Aug 11, 2026 |
| Richard D Spector | Chief Commercial Officer · Feb 12, 2024 – Feb 12, 2024 · Past |